The price of lenvatinib (a multi-target anti-tumor drug) is affected by factors such as specifications, region, and medical insurance policies. In China, the price per box is typically between 3000-6000 yuan. Imported original drugs are even more expensive. The out-of-pocket portion may be reduced after medical insurance reimbursement. Strict adherence to doctor's instructions is required; self-purchase or dosage adjustment is not permitted.
Price Range
The price of domestically produced lenvatinib (4mg x 30 tablets/box) is approximately 3000-5000 yuan, which may fluctuate in different regions due to differences in procurement policies or distribution costs.
The price of imported original drugs (same specifications) is typically 5000-6000 yuan per box. Costs can be reduced in some regions through medical insurance negotiations or charitable drug donation programs.
Medical Insurance Policies
Lenvatinib is included in my country's Category B medical insurance catalog, but only for specific indications (such as liver cancer, thyroid cancer, etc.) and reimbursement conditions must be met. The specific out-of-pocket percentage varies depending on regional policies (usually 30%-50%).
Patients can check reimbursement details through hospitals or local medical insurance departments. Some cities support a "dual-channel" purchase system (reimbursement is available at both hospitals and designated pharmacies).
Purchase Channels and Precautions
Lenvatinib is a prescription drug and must be purchased from hospitals or designated pharmacies with a doctor's prescription. Avoid obtaining it through informal channels (such as personal shoppers or online purchases) to prevent the risk of counterfeit drugs.
Side effects such as high blood pressure and proteinuria may occur during medication. Regular monitoring of liver and kidney function, blood pressure, and other indicators is necessary. Dosage adjustments or discontinuation of medication should be made according to the doctor's advice.
Medical Guidance
This drug is suitable for specific cancer patients and requires a prescription from an oncologist after assessing the patient's condition. Patients should not decide to take the medication on their own.
If financial pressure is significant, patients can apply for patient assistance programs from hospital social workers or pharmaceutical companies. Some programs offer drug cost reductions or installment payment options.
